Back to Search
Start Over
Xeris Biopharma announces positive results from phase 2 study of investigational XeriSol-formulated once-weekly SC levothyroxine to treat hypothyroidism
- Source :
- PharmaBiz. June 1, 2024
- Publication Year :
- 2024
-
Abstract
- Xeris Biopharma Holdings, Inc., a growth-oriented biopharmaceutical company committed to improving patients' lives by developing and commercializing innovative products across a range of therapies, announced topline results from its recently [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PharmaBiz
- Publication Type :
- Periodical
- Accession number :
- edsgcl.795987438